What Happened?
Monmouth Junction, NJ-based Elucida-Oncology Appointed Geno Germano as President and Chief Executive Officer
About the Company
Elucida Oncology, Inc., is a clinical development stage company based on proprietary ultra-small C-Dot technology to find, see and treat an array of solid tumor cancers. Developed and clinically translated by Memorial Sloan-Kettering Cancer Center and Cornell University, C-Dots have published human safety and tumor-specific clinical data. Elucida Oncology is currently progressing through a broad clinical trial program while continuing to drive a future portfolio through ongoing innovation.
About the Person
Geno Germano is President and Chief Executive Officer at Elucida Oncology. Previously, Geno held various senior HR leadership roles in the industry.
Info Source
News
Short Profile